Taysha Gene Therapies Announces Fast Track Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
Fast Track Designation (FTD) is designed to accelerate the development and expedite the review of…
News
Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
Digicann Ventures Announces Sale of Investment
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the…
Digicann Ventures Announces Sale of Investment
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the…
Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman
DOYLESTOWN, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or…
Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman
DOYLESTOWN, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or…
Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SAN DIEGO and TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SAN DIEGO and TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
– Combined full-year revenue and government support income increased 355% year-over-year – – Received guidance…
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
– Combined full-year revenue and government support income increased 355% year-over-year – – Received guidance…
A New Chilled Ritual is Here: Solei Cannabis Launches Its First Sparkling CBD Beverages
Enjoy The Real Fruit Juice Flavours of Solei’s Mango Passionfruit and Dragonfruit Watermelon now Available…
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company)…
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC…
ZEDEDA Introduces New Certification to Support Growing Use of Edge Computing
ZEDEDA Certified Edge Computing Associate (ZCEA) is a free, vendor-agnostic certification providing fundamental knowledge of…
OptimizeRx Expands AI Powered Omnichannel Platform
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a…